Some children who start antiretrovirals very early may control HIV after stopping treatment
Prostate cancer diagnosed later in US men with HIV
People-centred blood pressure management improves blood pressure in people with HIV
Six-country African PrEP study achieves high levels of persistence and good adherence in young women
Islatravir plus lenacapavir could be the first once-weekly oral HIV treatment
Broadly neutralising antibodies may be partners for long-acting antiretrovirals
HIV diagnoses continue to fall in US states with high PrEP coverage, while others are left behind
Once-weekly antiretrovirals on the horizon
If one antibody won’t work, how about three? Or three in one?
